These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 29315768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
    Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, Parsa A, Rossing P, Sigal RJ, Afkarian M, Aronson R, Caramori ML, Crandall JP, de Boer IH, Elliott TG, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Maahs DM, McGill JB, Molitch ME, Perkins BA, Polsky S, Pragnell M, Robiner WN, Rosas SE, Senior P, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, PERL Study Group.
    N Engl J Med; 2020 Jun 25; 382(26):2493-2503. PubMed ID: 32579810
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy.
    Kimura S, Inoguchi T, Yokomizo H, Maeda Y, Sonoda N, Takayanagi R.
    Diabetes Obes Metab; 2012 Jul 25; 14(7):666-9. PubMed ID: 22268518
    [Abstract] [Full Text] [Related]

  • 6. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC, Collaborative Study Group.
    Nephrology (Carlton); 2013 Jul 25; 18(7):516-24. PubMed ID: 23506627
    [Abstract] [Full Text] [Related]

  • 7. [The recovery of the kidney filtration functional reserve in diabetes mellitus patients on captopril treatment].
    Shestakova MV, Mukhin NA, Dedov II, Titov VN, Pomerantseva NV, Okunev DIu, Lipitskaia IIa.
    Ter Arkh; 1991 Jul 25; 63(6):50-5. PubMed ID: 1948747
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.
    Miao Y, Ottenbros SA, Laverman GD, Brenner BM, Cooper ME, Parving HH, Grobbee DE, Shahinfar S, de Zeeuw D, Lambers Heerspink HJ.
    Hypertension; 2011 Jul 25; 58(1):2-7. PubMed ID: 21632472
    [Abstract] [Full Text] [Related]

  • 13. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
    Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH.
    Kidney Int; 2003 May 25; 63(5):1874-80. PubMed ID: 12675866
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular risk factors and complications associated with albuminuria and impaired renal function in insulin-treated diabetes.
    Doggen K, Nobels F, Scheen AJ, Van Crombrugge P, Van Casteren V, Mathieu C.
    J Diabetes Complications; 2013 May 25; 27(4):370-5. PubMed ID: 23537603
    [Abstract] [Full Text] [Related]

  • 16. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.
    Momeni A, Shahidi S, Seirafian S, Taheri S, Kheiri S.
    Iran J Kidney Dis; 2010 Apr 25; 4(2):128-32. PubMed ID: 20404423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.
    Ranganathan S, Krempf M, Feraille E, Charbonnel B.
    Diabete Metab; 1993 Apr 25; 19(2):257-61. PubMed ID: 8339858
    [Abstract] [Full Text] [Related]

  • 19. Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
    Takashima H, Yoshida Y, Nagura C, Furukawa T, Tei R, Maruyama T, Maruyama N, Abe M.
    Diab Vasc Dis Res; 2018 Sep 25; 15(5):469-472. PubMed ID: 29923427
    [Abstract] [Full Text] [Related]

  • 20. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L, Janicke I, Bender R, Berger M, Sawicki PT.
    Horm Metab Res; 1996 Oct 25; 28(10):549-52. PubMed ID: 8934214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.